Banking Recap

Clearwater Analytics Holdings, Inc. Announces Acquisition

This transaction is a cash and stock acquisition in which Clearwater Analytics Holdings, Inc., a tech sector company, is acquiring Enfusion, Inc. The deal falls under the M&A product group, and the disclosed value is not stated in the source document.

Feb 11, 2025·SEC EDGAR (S-4)·pending regulatory·cash and stock acquisition

The facts in this summary are sourced from an SEC EDGAR Form S-4 filed and published on February 11, 2025. The transaction's current status is pending regulatory review.

Only one financial advisor is identified in the facts block: Goldman Sachs & Co. LLC served as financial advisor to the target, Enfusion, in a lead capacity, specifically advising the special committee. The source sentence notes consent language referencing Goldman Sachs & Co. LLC's opinion letter under the captions concerning the opinion of the special committee's financial advisor, indicating Goldman Sachs' engagement was tied to a special committee process at Enfusion rather than a general advisory mandate.

No legal advisors are identified in the facts block for either Enfusion or Clearwater Analytics.

The facts block characterizes this as a cash and stock acquisition, but provides no further detail on the specific mix or ratio of cash to stock consideration, the exchange ratio for any stock component, or other structural terms of the merger agreement.

Several material facts remain undisclosed. The transaction's dollar value is explicitly stated as not disclosed in the source document. No legal advisors are named for either party. No expected closing date is given, and the precise cash and stock consideration split is not specified beyond the general characterization of the subtype.